Wells Trecaso Financial Group, LLC Amgen Inc Transaction History

Wells Trecaso Financial Group, LLC

$304 Million
Q3 2024

A detailed history of Wells Trecaso Financial Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wells Trecaso Financial Group, LLC holds 1,930 shares of AMGN stock, worth $568,442. This represents 0.2% of its overall portfolio holdings.

Number of Shares

1,930

Previous 1,805 6.93%

Holding current value

$568,442

Previous $563,000 10.3%

% of portfolio

0.2%

Previous 0.19%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$309.38 - $337.38 $38,672 - $42,172	125 Added 6.93%	1,930 $621,000
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $10,772 - $13,091	41 Added 2.32%	1,805 $563,000
Q1 2024 Apr 24, 2024	BUY	$268.87 - $324.56 $19,358 - $23,368	72 Added 4.26%	1,764 $501,000
Q4 2023 Jan 19, 2024	BUY	$255.7 - $288.46 $255 - $288	1 Added 0.06%	1,692 $487,000
Q3 2023 Oct 23, 2023	SELL	$218.65 - $271.46 $43,511 - $54,020	-199 Reduced 10.53%	1,691 $454,000
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $2,356 - $2,787	11 Added 0.59%	1,890 $419,000
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $11,063 - $13,484	-49 Reduced 2.54%	1,879 $454,000
Q4 2022 Jan 27, 2023	BUY	$229.03 - $291.01 $229 - $291	1 Added 0.05%	1,928 $0
Q3 2022 Oct 24, 2022	SELL	$224.46 - $253.15 $3,591 - $4,050	-16 Reduced 0.82%	1,927 $434,000
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $10,151 - $11,296	-44 Reduced 2.21%	1,943 $473,000
Q1 2022 Apr 14, 2022	SELL	$219.27 - $242.57 $170,811 - $188,962	-779 Reduced 28.16%	1,987 $481,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $11,137 - $12,745	56 Added 2.07%	2,766 $622,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $4,669 - $5,471	-22 Reduced 0.81%	2,710 $576,000
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $4,204 - $4,664	18 Added 0.66%	2,732 $666,000
Q1 2021 Apr 19, 2021	BUY	$221.91 - $258.6 $13,536 - $15,774	61 Added 2.3%	2,714 $675,000
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $18,608 - $22,159	86 Added 3.35%	2,653 $610,000
Q3 2020 Oct 26, 2020	BUY	$234.65 - $260.95 $11,263 - $12,525	48 Added 1.91%	2,567 $652,000
Q2 2020 Jul 21, 2020	BUY	$197.81 - $242.74 $30,660 - $37,624	155 Added 6.56%	2,519 $594,000
Q1 2020 Apr 17, 2020	BUY	$182.24 - $241.7 $12,574 - $16,677	69 Added 3.01%	2,364 $479,000
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $7,757 - $9,971	41 Added 1.82%	2,295 $553,000
Q3 2019 Oct 16, 2019	SELL	$174.11 - $208.62 $1,218 - $1,460	-7 Reduced 0.31%	2,254 $436,000
Q2 2019 Jul 22, 2019	SELL	$166.7 - $195.41 $4,834 - $5,666	-29 Reduced 1.27%	2,261 $417,000
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $723 - $815	-4 Reduced 0.17%	2,290 $435,000
Q4 2018 Jan 28, 2019	BUY	$178.4 - $208.25 $26,224 - $30,612	147 Added 6.85%	2,294 $446,000
Q3 2018 Oct 22, 2018	SELL	$185.29 - $208.89 $9,264 - $10,444	-50 Reduced 2.28%	2,147 $445,000
Q2 2018 Jul 25, 2018	BUY	$166.05 - $186.51 $19,095 - $21,448	115 Added 5.52%	2,197 $406,000
Q1 2018 Apr 23, 2018	BUY	$169.43 - $198.0 $352,753 - $412,236	2,082 New	2,082 $355,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Trecaso Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wells Trecaso Financial Group, LLC with notifications on news.

Account

Wells Trecaso Financial Group, LLC Amgen Inc Transaction History